Annotated Medicine and Device Lists

Enoxaparin

Injection 100mg/ml in 0.4ml vial Injection 100mg/ml in 0.6ml vial Injection 60 mg (sodium) Injection 20 mg/0.2 mL Injection 40 mg/0.4 mL Injection 60 mg/0.6 mL Injection 80 mg/0.8 mL Injection 100 mg/1 mL Injection 120 mg/0.8 mL Injection 150 mg/1 mL

This medicine is present in:

List	Section	Observation
Peru	10.2 Medications that Affect Coagulation	No observations

This medicine is present in:

List	Section	Observation
Peru	10.2 Medications that Affect Coagulation	No observations

This medicine is present in:

List	Section	Observation
Venezuela (incomplete)	List of Generic Medications - Venezuela	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	10.2. Medicines affecting coagulation	Others observations: Including quality-assured biosimilars. Therapeutic alternatives: dalteparin, nadroparin

Information Resources: Enoxaparin

No information available